summary
Introduced
03/01/2018
03/01/2018
In Committee
03/01/2018
03/01/2018
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
End Taxpayer Subsidies for Drug Ads Act This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.
AI Summary
This bill, the End Taxpayer Subsidies for Drug Ads Act, amends the Internal Revenue Code to prohibit tax deductions for expenses related to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" refers to the dissemination of advertisements about a prescription drug product that are primarily targeted to the general public, such as through publications, broadcasting, and digital platforms. The bill aims to eliminate the tax incentive for pharmaceutical companies to engage in this type of advertising, which can contribute to rising healthcare costs.
Committee Categories
Budget and Finance
Sponsors (4)
Last Action
Read twice and referred to the Committee on Finance. (on 03/01/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/115th-congress/senate-bill/2478/all-info |
| BillText | https://www.congress.gov/115/bills/s2478/BILLS-115s2478is.pdf |
| Bill | https://www.congress.gov/115/bills/s2478/BILLS-115s2478is.pdf.pdf |
Loading...